Please use this identifier to cite or link to this item: http://ri.uaemex.mx/handle20.500.11799/109115
DC FieldValueLanguage
dc.creatorJosé Meneses Calderón-
dc.creatorJazmín Meneses Figueroa-
dc.creatorMaría Isabel Ospina Alzate-
dc.creatorIrma Socorro González Sánchez-
dc.creatorHugo Mendieta Zerón-
dc.date2020-03-
dc.date.accessioned2022-04-21T06:02:45Z-
dc.date.available2022-04-21T06:02:45Z-
dc.identifierhttp://hdl.handle.net/20.500.11799/109115-
dc.identifier.urihttp://ri.uaemex.mx/handle20.500.11799/109115-
dc.descriptionBACKGROUND: Autoimmune diseases complicate pregnancy in several manners. This study aimed at describing the most common complications in pregnant women with autoimmune diseases. METHODS: This was a descriptive and retrospective study. Two groups of pregnant women with autoimmune diseases were included: 1) Those who since the beginning of gestation received obstetrical care at a tertiary-level hospital and 2) Women who were treated first in a medical unit not specialized in rheumatological diseases. Odds ratio, logistic regression and multinomial logistic regression were used to determine risk of complicated pregnancy. RESULTS: The distribution of autoimmune diseases in our sample is as follows: systemic lupus erythematosus (SLE): 6, rheumatoid arthritis (RA): 4, primary anti-phospholipid syndrome (APS): 4, systemic sclerosis (SS): 2, mixed connective tissue disease (MCTD): 1. Eight patients were seen throughout their gestation at a tertiary-level hospital and nine were referred from other non-specialized hospitals. Patients in the first group had four complications, and those of the second group, 28. The Odds Ratio (OR) of having a complication in the hospitals of reference compared to the “Mónica Pretelini Sáenz” Maternal-Perinatal Hospital (HMPMPS) was of 29.8 (95% CI: 1.29-692.46; Z statistic 2.11, p = 0.03). In relation to the logistic regression, this test was not significant neither for the group nor the treatment scheme for the presence of at least one complication. The multinomial logistic regression did not show significant predictive probabilities of the different possible outcomes for the group and drug treatment scheme. CONCLUSION: Pregnant women with autoimmune diseases can have an OR up to 29.8 to develop complications when they are not cared for by specialized personnel.-
dc.languageeng-
dc.publisherRwanda Medical Journal-
dc.relation77-
dc.relation1-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0-
dc.source2079-097X-
dc.subjectComplications-
dc.subjectPregnant women-
dc.subjectAutoimmune diseases-
dc.subjectinfo:eu-repo/classification/cti/3-
dc.titleComplications in pregnant women with autoimmune diseases-
dc.typearticle-
dc.audiencestudents-
dc.audienceresearchers-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Collections:Producción
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.